U.S. markets open in 4 hours 52 minutes

TransMedics Group, Inc. (TMDX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
73.94+0.72 (+0.98%)
At close: 04:00PM EST
74.00 +0.06 (+0.08%)
After hours: 07:51PM EST

TransMedics Group, Inc.

200 Minuteman Road
Suite 302
Andover, MA 01810
United States
978 552 0900

IndustryMedical Devices
Full Time Employees212

Key Executives

NameTitlePayExercisedYear Born
Dr. Waleed H. Hassanein M.D.Founder, President, CEO & Director1.46M2.21M1968
Mr. Stephen GordonCFO, Treasurer & Secretary744.62k2.55M1968
Dr. Tamer I. Khayal M.D.Chief Commercial Officer748.78k3.15M1969
Ms. Miriam C. Provost Ph.D.Vice President of Global Regulatory Affairs535.93k390.25k1961
Mr. Nick CorcoranSenior Vice President of Supply Chain & OperationsN/AN/A1982
Mr. Mark AndersonSenior Director of Technology DevelopmentN/AN/AN/A
Mr. Anil RanganathSenior VP, General Counsel & Corporate SecretaryN/AN/AN/A
Ms. Susan GoodmanVice President of Human ResourcesN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Corporate Governance

TransMedics Group, Inc.’s ISS Governance QualityScore as of December 1, 2023 is 3. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.